Creative Planning - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
Creative Planning ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$352,830
-63.5%
3,873
-73.5%
0.00%
-100.0%
Q1 2023$965,522
+32.5%
14,638
+3.9%
0.00%0.0%
Q4 2022$728,439
+75.5%
14,087
+132.0%
0.00%0.0%
Q3 2022$415,000
+52.6%
6,071
+0.9%
0.00%
Q2 2022$272,000
-9.6%
6,014
+1.4%
0.00%
Q1 2022$301,000
+7.5%
5,9310.0%0.00%
Q4 2021$280,0005,9310.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders